Advertisement
Advertisement
Cottonindo Ariesta markets its products under in-house brands Wellness and Mawar.

Cottonindo Ariesta set to spin cotton business into global brand

Supported by:Discovery Reports

The first modern facial cotton company in Indonesia, Cottonindo Ariesta knows that the key to turning one of the most commonly used everyday products into the most essential lies in quality, consistency and innovation.

Cottonindo is the country’s only integrated cotton producer that processes products from raw materials to finished goods – for applications ranging from personal use to medical cotton for hospitals and semi-finished products for industrial use such as bleached cotton and cotton sliver.

“We have prevailed through major challenges – the toughest of which was the 1997 Asian financial crisis – because we believed in our products, their importance and their fundamental role in an increasingly health and wellness-conscious market,” says president and director Marting Djapar.

This outlook, combined with Cottonindo’s commitment to excellence, has made the company the partner of choice for private labels and home brands for nationwide supermarkets and international chain stores including Carrefour, Lotte Mart, Hypermart, Indomaret and Alfamart.

“Indonesia is a lucrative market with more than 260 million consumers. We seek experienced partners to grow with us here and in other Asian markets, where we hope to share our expertise”
Marting Djapar, president and director, Cottonindo Ariesta

With a network comprising about

60 distributors and partners, Cottonindo also markets its products under in-house brands Wellness and Mawar, for which the company envisions a broader reach as it pursues further expansion.

Cottonindo began its global foray in 2006 through exhibitions, and has since been exporting to mainland China, Taiwan, Saudi Arabia, Russia, Malaysia, Thailand, Vietnam, South Africa and Australia.

Cottonindo welcomes local and foreign investors, especially as it prepares to launch its initial public offering this year. Once it goes public, the company aims to expand its

medical products segment, targeting hospitals and health care institutions.

“Indonesia is a lucrative market with more than 260 million consumers,” Djapar says. “We seek experienced partners to grow with us here and in other Asian markets, where we hope to share our expertise.”

Post